top of page

Biopharma Stock Updates - 12/10/20

Data Updates:

$BNTX (+3.66%) - Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine

$MRNA (+1.00%) - First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine

$RGNX - (+2.83%) - Dosing Of First Patient In Phase II ALTITUDE™ Trial Of RGX-314 For The Treatment Of Diabetic Retinopathy Using Suprachoroidal Delivery

$SPRO (-1.03%) - First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease

$TGTX (+22.28%) - Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple Sclerosis


$KALV (+0.50%) - Reports Second Fiscal Quarter Results

$NLTX (+1.17%) - Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer

$PTGX (-11.37%) –Public offering of$100,000,000 of shares of its common stock

bottom of page